Seelos Therapeutics Debt 2024

Seelos Therapeutics Aktienanalyse

What does Seelos Therapeutics do?

Seelos Therapeutics Inc is an emerging company in the biotechnology industry that focuses on the development of novel therapeutics for patients with unmet medical needs. The company was founded in 2016 by Raj Mehra and is headquartered in New York City. Seelos Therapeutics Inc specializes in the development of therapeutics for neurological and psychiatric disorders, with a focus on treating patients with severe, chronic, or life-threatening conditions. The company has developed an innovative business model based on collaboration with various institutions, organizations, and companies. The company is divided into several divisions, including clinical development, product development, technology development, and strategic partnerships. Each division focuses on specific aspects of therapy development and contributes to Seelos' ability to develop innovative and effective therapeutics for its patients. In the clinical development division, Seelos Therapeutics Inc focuses on conducting clinical trials to assess the efficacy and safety of its therapeutics. The company works closely with various academic institutions and clinics to conduct its clinical studies and ensure they adhere to the highest scientific standards. The product development division is responsible for the development of Seelos' actual therapeutics. It encompasses research, development, manufacturing, and quality assurance of the company's products. Seelos emphasizes rigorous quality and safety management to ensure its products meet the highest standards. In the technology development division, Seelos focuses on developing innovative technologies for therapy development. In collaboration with various institutions and companies, the company invests in the development of new technologies to improve its therapeutics and optimize patient care. A crucial aspect of Seelos' business model is collaboration with other companies and institutions. The company has formed strategic partnerships with various institutions and companies in the biotechnology and pharmaceutical fields. This allows Seelos to leverage the expertise and resources of other companies and expedite the development of its therapeutics. Seelos' flagship product is SLS-002, a novel rapid-onset nasal ketamine for the treatment of suicidality in patients with depression and bipolar disorder. SLS-002 has shown promising results in clinical trials and is currently in Phase 2b of clinical development. Seelos is also working on the development of therapeutics for other neurological and psychiatric disorders, such as Huntington's disease, neuropathic pain, and Amyotrophic Lateral Sclerosis (ALS). Overall, Seelos Therapeutics Inc is an emerging company in the biotechnology industry that focuses on the development of novel therapeutics for patients with unmet medical needs. Through its innovative business model and collaboration with other companies and institutions, Seelos aims to expedite the development of its therapeutics and improve the lives of patients with severe, chronic, or life-threatening conditions. Seelos Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Seelos Therapeutics's Debt Structure

Seelos Therapeutics's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Seelos Therapeutics's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Seelos Therapeutics’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Seelos Therapeutics’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Seelos Therapeutics stock

What is the debt of Seelos Therapeutics this year?

Seelos Therapeutics has a debt level of 11.22 USD this year.

What was the debt of Seelos Therapeutics compared to the previous year?

The debt of Seelos Therapeutics has increased by 148.38% compared to the previous year increased.

What are the consequences of high debt for investors in Seelos Therapeutics?

High debt can pose a risk for investors of Seelos Therapeutics, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Seelos Therapeutics?

Low debt means that Seelos Therapeutics has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Seelos Therapeutics affect the company?

An increase in debt of Seelos Therapeutics can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Seelos Therapeutics affect the company?

A reduction in debt of Seelos Therapeutics can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Seelos Therapeutics?

Some factors that can influence the debt of Seelos Therapeutics include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Seelos Therapeutics so important for investors?

The debts of Seelos Therapeutics are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Seelos Therapeutics take to change the debt?

To change the debt, Seelos Therapeutics can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Seelos Therapeutics pay?

Over the past 12 months, Seelos Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Seelos Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Seelos Therapeutics?

The current dividend yield of Seelos Therapeutics is .

When does Seelos Therapeutics pay dividends?

Seelos Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Seelos Therapeutics?

Seelos Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Seelos Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Seelos Therapeutics located?

Seelos Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Seelos Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Seelos Therapeutics from 10/6/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/6/2024.

When did Seelos Therapeutics pay the last dividend?

The last dividend was paid out on 10/6/2024.

What was the dividend of Seelos Therapeutics in the year 2023?

In the year 2023, Seelos Therapeutics distributed 0 USD as dividends.

In which currency does Seelos Therapeutics pay out the dividend?

The dividends of Seelos Therapeutics are distributed in USD.